Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Astrocytoma

Below is an extended Astrocytoma news listing. Click here to return to the Astrocytoma main in depth entry.

BioNews Results for Astrocytoma:
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Temozolomide Teva Pharma Live: Nov 20 2009 5:10PM Matching: astrocytoma
Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Temomedac Pharma Live: Nov 20 2009 5:10PM Matching: astrocytoma
Research and Markets: Competitor Analysis: TGF-R Agonists and Antagonists - A Competitor Evaluation in the Field of Transforming Growth Factor Recepto Yahoo! Canada: Nov 11 2009 3:11PM Matching: astrocytoma
Findings May Spur Development of Drugs to Treat Brain Tumors in Infants Biotech Daily: Nov 9 2009 4:22PM Matching: astrocytoma
Caspase-dependent generation of reactive oxygen species in human astrocytoma cells contributes to resistance to TRAIL-mediated apoptosis Cell Death and Differentiation: Oct 30 2009 3:20PM Matching: astrocytoma
Mutation linked to pediatric brain tumor may pave way for targeted treatment Washington University in St. Louis: Oct 29 2009 10:24PM Matching: astrocytoma
Analysis of the mismatched manifestation between rCBF and rCBV maps in cerebral astrocytomas Clinical Imaging: Oct 28 2009 7:25AM Matching: astrocytoma
Health Canada approves Antisense Pharma's clinical Phase III study SAPPHIRE in aggressive brain tumors Pharma Live: Oct 20 2009 7:32AM Matching: astrocytoma
HK reports 32nd A/H1N1 flu death case CHINAdaily: Oct 20 2009 3:57PM Matching: astrocytoma
HK reports 32nd A/H1N1 flu death case Xinhua News Agency: Oct 20 2009 3:55PM Matching: astrocytoma
Antisense Pharma receives Health Canada approval for pivotal Phase III clinical trial SAPPHIRE Therapeutics Daily: Oct 20 2009 9:24AM Matching: astrocytoma
Health Canada approves Antisense Pharma's clinical Phase III study SAPPHIRE in aggressive brain tumors CNW Telbec: Oct 19 2009 2:43PM Matching: astrocytoma
Health Canada Approves Antisense Pharma's Clinical Phase III Study SAPPHIRE in Aggressive Brain Tumors Therapeutics Daily: Oct 19 2009 12:23PM Matching: astrocytoma
Health Canada approves Antisense Pharma's clinical Phase III study SAPPHIRE in aggressive brain tumors Canadian Business Magazine: Oct 19 2009 11:33AM Matching: astrocytoma
Health Canada approves Antisense Pharma's clinical Phase III study SAPPHIRE in aggressive brain tumors Canadian Business Magazine: Oct 19 2009 11:33AM Matching: astrocytoma

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.